97 results
Page 3 of 5
8-K
EX-99.1
e3x02yo3w7nf it4bri
1 Oct 19
Adaptimmune Announces Appointment of Michael Garone as Interim Chief Financial Officer
8:14am
8-K
aw637 xd9bcvw
1 Oct 19
Adaptimmune Announces Appointment of Michael Garone as Interim Chief Financial Officer
8:14am
8-K
EX-10.1
hma6ewh zr
27 Aug 19
Entry into a Material Definitive Agreement
8:39am
8-K/A
EX-99.1
si0m8 c5sc4c15d
27 Feb 19
CORRECTING and REPLACING — Adaptimmune Reports Fourth Quarter / Full Year 2018 Financial Results and Business Update
5:16pm
8-K
EX-99.1
5dgji
27 Feb 19
Adaptimmune Reports Fourth Quarter / Full Year 2018 Financial Results and Business Update
7:43am
CORRESP
jo3v lefjrwj
18 Oct 18
Correspondence with SEC
12:00am
8-K
ao67807yjolje9d bb
24 Jul 18
GSK and Adaptimmune Complete Transition of NY-ESO SPEAR T-cell Therapy Program to GSK
7:36am
8-K
EX-99.1
3d4cl7s 2q
24 Jul 18
GSK and Adaptimmune Complete Transition of NY-ESO SPEAR T-cell Therapy Program to GSK
7:36am